Evidence map›Paper›PMID 20116856›Full record

ArticleMolecular immunology2010

Requirement for ubiquitin conjugation and 26S proteasome activity at an early stage in V(D)J recombination.

Anamika Bhattacharyya, Jessica M Jones

Abstract read
In one paragraph

Article in Molecular immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anamika BhattacharyyaDepartment of Biochemistry and Molecular and Cellular Sciences, Georgetown University, Washington, DC 20057, USA.
Jessica M Jones
Georgetown University · US

Funding

Role of RAG1 Ubiquitin Ligase Activity in RecombinationR01AI062854 · NIAID · GEORGETOWN UNIVERSITY · PI JONES, JESSICA MORGAN · 2005 to 2009
$1.3M
NIAID NIH HHS R01 AI062854NIAID NIH HHS R01AI062854
6 · The paper itself

Abstract

V(D)J recombination, the process that rearranges gene segments to assemble mature antigen receptor genes, relies on a recombinase comprising the RAG1 and RAG2 proteins. RAG1 is a multi-functional enzyme including DNA binding and cleavage as well as ubiquitin ligase activities, all of which appear to contribute to its role in recombination. Here we demonstrate that components of the ubiquitin conjugation machinery and the 26S proteasome are required for an early step in V(D)J recombination. Inhibitors of the 26S proteasome and ubiquitin activating enzyme (E1) blocked both chromosomal and extra-chromosomal recombination when added 1h following transfection/induction, but they had no effect when added 16 h later. There was no effect on expression of RAG1, and recombination did not require transit through the cell cycle, confirming that inhibition was not due to an indirect effect on cell cycle arrest or protein expression. Experiments in which RAG1 translation was blocked with cyclohexamide after 16 h of expression indicated that many active recombination complexes were formed within this window, although recombination products continued to accumulate for 48 h. These data suggest that ubiquitin-dependent degradation is an early step in complex assembly or activation, and are consistent with our previous hypothesis that degradation of a negative regulator is required to trigger recombination.

Indexed as

AnimalsCHO CellsChromosomes, MammalianCricetinaeCricetulusDNA ReplicationGene RearrangementMiceProteasome Endopeptidase ComplexProtein BiosynthesisRecombination, GeneticSubstrate SpecificityTime FactorsTransfectionUbiquitinUbiquitin-Activating EnzymesATP dependent 26S proteaseProteasome Endopeptidase ComplexUbiquitinUbiquitin-Activating Enzymes

Identifiers

PMID20116856
PMCPMC2830333
OpenAlexW1993693442

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.